Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan O Martinez

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
Frontiers in Bioengineering and Biotechnology|December 20, 2021
LDL-Based Lipid Nanoparticle Derived for Blood Plasma Accumulates Preferentially in Atherosclerotic PlaqueChristian A Boada, Assaf Zinger, Scott Rohen, et al.
Biomaterials|January 14, 2016
Cell source determines the immunological impact of biomimetic nanoparticlesMichael Evangelopoulos, Alessandro Parodi, Jonathan O Martinez, et al.
Pharmacological Research|January 5, 2010
Enabling individualized therapy through nanotechnologyJason H Sakamoto, Anne L van de Ven, Biana Godin, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 22, 2020
Phosphoprotein-based biomarkers as predictors for cancer therapyAngela M Carter, Chunfeng Tan, Karine Pozo, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
Frontiers in Bioengineering and Biotechnology|December 20, 2021
LDL-Based Lipid Nanoparticle Derived for Blood Plasma Accumulates Preferentially in Atherosclerotic PlaqueChristian A Boada, Assaf Zinger, Scott Rohen, et al.
Biomaterials|January 14, 2016
Cell source determines the immunological impact of biomimetic nanoparticlesMichael Evangelopoulos, Alessandro Parodi, Jonathan O Martinez, et al.
Pharmacological Research|January 5, 2010
Enabling individualized therapy through nanotechnologyJason H Sakamoto, Anne L van de Ven, Biana Godin, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 22, 2020
Phosphoprotein-based biomarkers as predictors for cancer therapyAngela M Carter, Chunfeng Tan, Karine Pozo, et al.
Pageof 4